Security Snapshot

Prestige Consumer Healthcare Inc. - Common Stock SH (PBH) Institutional Ownership

CUSIP: 74112D101

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

317

Shares (Excl. Options)

53.76MFull value: 53,761,748 · shares · 30 Jun 2026

Price

$47.27

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock SH
Symbol
PBH on NYSE
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
53,761,748
Latest holder snapshot 5 signals
Total 13F value
$2,544,088,407
Portfolio coverage rank
0%
Share change
+1,731,644
Value change
+$42,829,934
Number of holders
317
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
47,269,039
SEC-reported price per share
$45.87
Insider filing price
$45.87
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • PBH - Prestige Consumer Healthcare Inc. - Common Stock SH is tracked under CUSIP 74112D101.
  • 317 institutions reported positions in Q2 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 353 to 317 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $3.08BFull value: $3,076,558,524 · USD · 31 Mar 2026
    to
    $2.54BFull value: $2,544,088,407 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 317 institutions filings for Q2 2026.

Open SEC evidence

Security key

74112D101

13F reference period

Q2 2026

13F holders

317

13D/G owners

6

CIK / CUSIP context first

Open Q2 2026 holders PBH full holder history Prestige Consumer Healthcare Inc. SEC filings Prestige Consumer Healthcare Inc. company facts Prestige Consumer Healthcare Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
PBH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $609,115,318 7,524,587 BlackRock, Inc. 31 Mar 2025
ARIEL INVESTMENTS, LLC 10% +20% $230,162,470 +$36,221,847 4,868,711 +19% Ariel Investments, LLC 30 Jun 2026
DIMENSIONAL FUND ADVISORS LP 5.9% $235,326,993 2,907,066 Dimensional Fund Advisors LP 31 Dec 2024
VANGUARD PORTFOLIO MANAGEMENT LLC 6% $167,528,789 2,826,536 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $145,506,309 2,454,974 Vanguard Capital Management 31 Mar 2026
MACQUARIE GROUP LTD 4.7% $186,914,926 2,309,017 Macquarie Group Limited 31 Dec 2024
As of 30 Jun 2026, 317 institutional investors reported holding
53.76MFull value: 53,761,748 · shares · 30 Jun 2026
shares of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH). This represents 114% of the company’s total
47.27MFull value: 47,269,039 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
87%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 17% 7,831,333 +6% 0.01% $370,187,111
ARIEL INVESTMENTS, LLC 10% 4,868,711 +14% 2.3% $230,143,970
VANGUARD PORTFOLIO MANAGEMENT LLC 6% 2,825,340 +0.77% 0.01% $133,553,822
DIMENSIONAL FUND ADVISORS LP 5.6% 2,661,291 -0.43% 0.02% $125,802,061
FULLER & THALER ASSET MANAGEMENT, INC. 4.9% 2,331,821 0.3% $110,225,175
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 2,136,944 +2.1% 0% $101,013,343
STATE STREET CORP 4.5% 2,116,513 +7.4% 0% $100,047,570
BRANDES INVESTMENT PARTNERS, LP 4.3% 2,051,060 +140% 0.68% $96,953,606
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4% 1,872,023 -15% 0.27% $88,490,528
GEODE CAPITAL MANAGEMENT, LLC 3.3% 1,571,742 +7.7% 0% $74,306,032
Allspring Global Investments Holdings, LLC 2.7% 1,271,950 -18% 0.09% $61,257,112
MORGAN STANLEY 2.6% 1,243,931 -8.4% 0% $58,800,671
NORDEA INVESTMENT MANAGEMENT AB 1.8% 828,628 +38% 0.03% $39,252,108
NORTHERN TRUST CORP 1.6% 773,449 +3.1% 0% $36,560,934
WESTWOOD HOLDINGS GROUP INC 1.6% 750,445 -33% 0.27% $35,473,535
RICE HALL JAMES & ASSOCIATES, LLC 1.5% 689,692 +32% 1.6% $32,601,741
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.4% 658,659 +39% 0.02% $31,134,811
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 654,174 -12% 0% $30,922,805
UBS Group AG 1.4% 638,605 +63% 0% $30,186,858
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.3% 629,836 +5.3% 0.01% $29,772,348
Boston Trust Walden Corp 1.3% 609,949 -5.2% 0.22% $28,832,289
GOLDMAN SACHS GROUP INC 1.2% 586,536 +28% 0% $27,725,541
CITADEL ADVISORS LLC 1.2% 564,157 +208% 0.02% $26,667,701
BANK OF AMERICA CORP /DE/ 1.2% 555,894 +1.5% 0% $26,277,109
RAYMOND JAMES FINANCIAL INC 0.98% 464,353 -17% 0.01% $21,949,967

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,089,480 $49,676,646 +$10,512,468 $45.87 49
2026 Q2 53,761,748 $2,544,088,407 +$42,829,934 $47.27 317
2026 Q1 51,965,194 $3,076,558,524 +$20,318,471 $59.27 353
2025 Q4 51,625,462 $3,184,309,811 -$39,666,152 $61.69 354
2025 Q3 50,810,480 $3,171,948,668 -$74,667,802 $62.40 351
2025 Q2 52,028,208 $4,154,947,022 +$68,664,201 $79.85 372
2025 Q1 51,179,850 $4,399,098,887 -$94,834,306 $85.97 354
2024 Q4 52,470,130 $4,096,580,344 +$88,611,492 $78.09 335
2024 Q3 51,041,422 $3,683,307,685 +$3,200,629 $72.10 323
2024 Q2 51,067,584 $3,515,715,953 -$4,889,638 $68.85 305
2024 Q1 51,320,692 $3,722,982,898 +$23,075,777 $72.56 311
2023 Q4 51,115,027 $3,129,318,451 +$6,370,695 $61.22 287
2023 Q3 50,946,303 $2,913,995,592 +$55,643,279 $57.19 279
2023 Q2 49,864,351 $2,965,000,913 -$29,425,137 $59.43 273
2023 Q1 50,365,220 $3,154,009,517 +$46,802,032 $62.63 280
2022 Q4 50,007,293 $3,131,794,375 +$2,107,559 $62.60 286
2022 Q3 50,088,729 $2,496,799,721 -$37,445,090 $49.83 270
2022 Q2 50,591,595 $2,974,240,060 +$45,867,050 $58.80 273
2022 Q1 50,360,901 $2,667,571,389 -$38,075,618 $52.94 269
2021 Q4 50,531,110 $3,065,040,827 -$86,724,122 $60.65 261
2021 Q3 50,742,397 $2,847,713,877 -$66,715,011 $56.11 240
2021 Q2 51,943,459 $2,706,851,067 -$30,851,217 $52.10 219
2021 Q1 52,622,155 $2,319,703,648 +$13,619,119 $44.08 233
2020 Q4 52,481,635 $1,830,396,086 -$33,067,279 $34.87 227
2020 Q3 53,391,500 $1,942,255,015 -$69,442,046 $36.42 233
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .